Korean J Physiol Pharmacol.  2021 Jan;25(1):87-94. 10.4196/kjpp.2021.25.1.87.

Nootkatol prevents ultraviolet radiation-induced photoaging via ORAI1 and TRPV1 inhibition in melanocytes and keratinocytes

Affiliations
  • 1Department of Physiology, Dongguk University College of Medicine, Gyeongju 38066, Korea
  • 2Channelopathy Research Center (CRC), Dongguk University College of Medicine, Goyang 10326, Korea
  • 3Avixgen, Seoul 06649, Korea
  • 4Department of Internal Medicine, Graduate School of Medicine, Dongguk University, Goyang 10326, Korea

Abstract

Skin photoaging occurs due to chronic exposure to solar ultraviolet radiation (UV), the main factor contributing to extrinsic skin aging. Clinical signs of photoaging include the formation of deep, coarse skin wrinkles and hyperpigmentation. Although melanogenesis and skin wrinkling occur in different skin cells and have different underlying mechanisms, their initiation involves intracellular calcium signaling via calcium ion channels. The ORAI1 channel initiates melanogenesis in melanocytes, and the TRPV1 channel initiates MMP-1 production in keratinocytes in response to UV stimulation. We aimed to develop a drug that may simultaneously inhibit ORAI1 and TRPV1 activity to help prevent photoaging. We synthesized nootkatol, a chemical derivative of valencene. TRPV1 and ORAI1 activities were measured using the whole-cell patch-clamp technique. Intracellular calcium concentration [Ca2+ ] i was measured using calcium-sensitive fluorescent dye (Fura-2 AM). UV-induced melanin formation and MMP-1 production were quantified in B16F10 melanoma cells and HaCaT cells, respectively. Our results indicate that nootkatol (90 μM) reduced TRPV1 current by 94% ± 2% at –60 mV and ORAI1 current by 97% ± 1% at –120 mV. Intracellular calcium signaling was significantly inhibited by nootkatol in response to ORAI1 activation in human primary melanocytes (51.6% ± 0.98% at 100 μM). Additionally, UV-induced melanin synthesis was reduced by 76.38% ± 5.90% in B16F10 melanoma cells, and UV-induced MMP-1 production was reduced by 59.33% ± 1.49% in HaCaT cells. In conclusion, nootkatol inhibits both TRPV1 and ORAI1 to prevent photoaging, and targeting ion channels may be a promising strategy for preventing photoaging.

Keyword

Ion channel; Nootkatol; ORAI1 protein; Skin aging

Figure

  • Fig. 1 Inhibitory effects of nootkatol on the human TRPV1 (hTRPV1) and human ORAI1 (hORAI1) currents. (A) Representative chart trace recording of hTRPV1 inhibited by nootkatol in hTRPV1-overexpressing HEK293T cells. The solid line indicates the holding current, whereas solid bars indicate the corresponding current induced by ramp-like pulse. After hTRPV1 activation by 1 µM capsaicin, the marked states indicate the steady-state currents of each condition, namely control (1) and treatment with 10 (2), 30 (3), and 90 µM (4) nootkatol. (B) Related current-voltage (I–V) relationship curve at the steady-state of the control (1) and cells treated with 10 (2), 30 (3), and 90 µM (4) nootkatol. (C) Summary of current inhibition by nootkatol treatment. Current amplitude is normalized to control current at –60 mV (mean ± standard error of the mean [SEM], n = 7, 4, 4, 7, respectively) (***p < 0.001). (D) Representative chart trace recording of hORAI1 inhibited by nootkatol in hORAI1-overexpressing HEK293T cells. (E) Related current-voltage (I–V) relationship curve at the steady-state of the control (1) and cells treated with 10 (2), 30 (3), and 90 µM (4) nootkatol. (F) Summary of the current level of hORAI1 upon nootkatol treatment. Current amplitude is normalized to control current at –120 mV (mean ± SEM, n = 7, 6, 6, 4, respectively) (***p < 0.001).

  • Fig. 2 Inhibition of thapsigargin-induced store-operated Ca2+ entry (SOCE) by nootkatol in primary human melanocytes. (A) Representative trace for intracellular Ca2+ measurement by Fura-2 in primary human melanocytes. Treatment with 10 and 100 µM nootkatol after the 2 mM Ca2+ add-back procedure partially inhibited [Ca2+]i. To confirm the basal [Ca2+]i, 10 µM BTP2, a potent ORAI1 inhibitor, was used. Asterisks (*) indicate the “time point” for each chemical treatment. (B) Summary of the inhibitory effects of 10 and 100 µM nootkatol and 10 µM BTP2 on [Ca2+]i in primary human melanocytes. ***p < 0.001 vs. the control (mean ± standard error of the mean, n = 8).

  • Fig. 3 Inhibitory effect of nootkatol on ultraviolet radiation (UV)-induced melanogenesis. (A) In the cytotoxicity assay performed with B16F10 cells, nootkatol-treated cells showed 99.22% ± 0.70%, 98.36% ± 1.65%, 99.20% ± 0.52%, 97.80% ± 1.07%, 62.29% ± 2.45%, and 22.06% ± 1.26% cell survival rate at 7.5, 15, 30, 60, 120, and 200 µg/ml, respectively (mean ± standard error of the mean [SEM], n = 3). (B) The inhibitory effect on UV-induced melanogenesis in B16F10 cells was 84.14% ± 1.54% and 76.38% ± 5.90% at 7.5 µg/ml and 15 µg/ml nootkatol, respectively. Kojic acid showed 78.12% ± 7.29% melanin inhibition at 15 µg/ml (mean ± SEM, n = 3) (***p < 0.001). (C) Direct tyrosinase inhibitory activity of 200 µM nootkatol and kojic acid (positive control) (mean ± SEM, n = 3) (****p < 0.0001).

  • Fig. 4 Effects of nootkatol on ultraviolet radiation (UV)-induced matrix metalloproteinase-1 (MMP-1) production. (A) Treatment with 7.5, 15, 30, 60, 120, and 240 µg/ml nootkatol showed 111.37% ± 2.88%, 91.33% ± 2.74%, 27.24% ± 3.73%, 21.59% ± 0.51%, 21.50% ± 0.75%, and 20.65% ± 0.23% cell viability, respectively (n = 3). (B) MMP-1 level, expressed as % of control, following exposure to UVB irradiation (16 mJ/cm2) alone and with nootkatol pretreatment (7.5 µg/ml, 59.33% ± 1.49%) (mean ± standard error of the mean, n = 3) (****p < 0.0001).


Cited by  1 articles

Flos magnoliae constituent fargesin has an anti-allergic effect via ORAI1 channel inhibition
Phan Thi Lam Hong, Hyun Jong Kim, Woo Kyung Kim, Joo Hyun Nam
Korean J Physiol Pharmacol. 2021;25(3):251-258.    doi: 10.4196/kjpp.2021.25.3.251.


Reference

1. Gupta MA, Gilchrest BA. 2005; Psychosocial aspects of aging skin. Dermatol Clin. 23:643–648. DOI: 10.1016/j.det.2005.05.012. PMID: 16112440.
Article
2. Shanbhag S, Nayak A, Narayan R, Nayak UY. 2019; Anti-aging and sunscreens: paradigm shift in cosmetics. Adv Pharm Bull. 9:348–359. DOI: 10.15171/apb.2019.042. PMID: 31592127. PMCID: PMC6773941.
Article
3. Dobos G, Lichterfeld A, Blume-Peytavi U, Kottner J. 2015; Evaluation of skin ageing: a systematic review of clinical scales. Br J Dermatol. 172:1249–1261. DOI: 10.1111/bjd.13509. PMID: 25363020.
Article
4. Farage MA, Miller KW, Elsner P, Maibach HI. 2008; Intrinsic and extrinsic factors in skin ageing: a review. Int J Cosmet Sci. 30:87–95. DOI: 10.1111/j.1468-2494.2007.00415.x. PMID: 18377617.
Article
5. Kohl E, Steinbauer J, Landthaler M, Szeimies RM. 2011; Skin ageing. J Eur Acad Dermatol Venereol. 25:873–884. DOI: 10.1111/j.1468-3083.2010.03963.x. PMID: 21261751.
Article
6. Amaro-Ortiz A, Yan B, D'Orazio JA. 2014; Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation. Molecules. 19:6202–6219. DOI: 10.3390/molecules19056202. PMID: 24838074. PMCID: PMC4344124.
Article
7. Rattanawiwatpong P, Wanitphakdeedecha R, Bumrungpert A, Maiprasert M. 2020; Anti-aging and brightening effects of a topical treatment containing vitamin C, vitamin E, and raspberry leaf cell culture extract: a split-face, randomized controlled trial. J Cosmet Dermatol. 19:671–676. DOI: 10.1111/jocd.13305. PMID: 31975502. PMCID: PMC7027822.
Article
8. Gilchrest BA. 2013; Photoaging. J Invest Dermatol. 133(E1):E2–E6. DOI: 10.1038/skinbio.2013.176. PMID: 23820721.
Article
9. Krutmann J, Morita A, Chung JH. 2012; Sun exposure: what molecular photodermatology tells us about its good and bad sides. J Invest Dermatol. 132(3 Pt 2):976–984. DOI: 10.1038/jid.2011.394. PMID: 22170486.
Article
10. Park HY, Kosmadaki M, Yaar M, Gilchrest BA. 2009; Cellular mechanisms regulating human melanogenesis. Cell Mol Life Sci. 66:1493–1506. DOI: 10.1007/s00018-009-8703-8. PMID: 19153661.
Article
11. Schieke SM. 2003; [Photoaging and infrared radiation. Novel aspects of molecular mechanisms]. Hautarzt. 54:822–824. German. DOI: 10.1007/s00105-003-0577-3. PMID: 12955258.
12. Choi TY, Park SY, Jo JY, Kang G, Park JB, Kim JG, Hong SG, Kim CD, Lee JH, Yoon TJ. 2009; Endogenous expression of TRPV1 channel in cultured human melanocytes. J Dermatol Sci. 56:128–130. DOI: 10.1016/j.jdermsci.2009.07.002. PMID: 19656659.
Article
13. Kusumaningrum N, Lee DH, Yoon HS, Kim YK, Park CH, Chung JH. 2018; Gasdermin C is induced by ultraviolet light and contributes to MMP-1 expression via activation of ERK and JNK pathways. J Dermatol Sci. 90:180–189. DOI: 10.1016/j.jdermsci.2018.01.015. PMID: 29428815.
Article
14. Kusumaningrum N, Lee DH, Yoon HS, Park CH, Chung JH. 2018; Ultraviolet light-induced gasdermin C expression is mediated via TRPV1/calcium/calcineurin/NFATc1 signaling. Int J Mol Med. 42:2859–2866. DOI: 10.3892/ijmm.2018.3839. PMID: 30226565.
Article
15. Lee DU, Weon KY, Nam DY, Nam JH, Kim WK. 2016; Skin protective effect of guava leaves against UV-induced melanogenesis via inhibition of ORAI1 channel and tyrosinase activity. Exp Dermatol. 25:977–982. DOI: 10.1111/exd.13151. PMID: 27488812.
Article
16. Nam JH, Lee DU. 2015; Inhibitory effect of oleanolic acid from the rhizomes of Cyperus rotundus on transient receptor potential vanilloid 1 channel. Planta Med. 81:20–25. DOI: 10.1055/s-0034-1383304. PMID: 25402944.
Article
17. Nam JH, Lee DU. 2016; Foeniculum vulgare extract and its constituent, trans-anethole, inhibit UV-induced melanogenesis via ORAI1 channel inhibition. J Dermatol Sci. 84:305–313. DOI: 10.1016/j.jdermsci.2016.09.017. PMID: 27712859.
Article
18. Nam JH, Nam DY, Lee DU. 2016; Valencene from the rhizomes of Cyperus rotundus inhibits skin photoaging-related ion channels and Uv-induced melanogenesis in B16F10 melanoma cells. J Nat Prod. 79:1091–1096. DOI: 10.1021/acs.jnatprod.5b01127. PMID: 26967731.
Article
19. Motiani RK, Tanwar J, Raja DA, Vashisht A, Khanna S, Sharma S, ivastava S Sr, Sivasubbu S, Natarajan VT, Gokhale RS. 2018; STIM1 activation of adenylyl cyclase 6 connects Ca2+ and cAMP signaling during melanogenesis. EMBO J. 37:e97597. DOI: 10.15252/embj.201797597. PMID: 29311116. PMCID: PMC5830913.
Article
20. Stanisz H, Stark A, Kilch T, Schwarz EC, Müller CS, Peinelt C, Hoth M, Niemeyer BA, Vogt T, Bogeski I. 2012; ORAI1 Ca2+ channels control endothelin-1-induced mitogenesis and melanogenesis in primary human melanocytes. J Invest Dermatol. 132:1443–1451. DOI: 10.1038/jid.2011.478. PMID: 22318387.
21. Stanisz H, Vultur A, Herlyn M, Roesch A, Bogeski I. 2016; The role of Orai-STIM calcium channels in melanocytes and melanoma. J Physiol. 594:2825–2835. DOI: 10.1113/JP271141. PMID: 26864956. PMCID: PMC4887671.
Article
22. Lee YM, Kim YK, Chung JH. 2009; Increased expression of TRPV1 channel in intrinsically aged and photoaged human skin in vivo. Exp Dermatol. 18:431–436. DOI: 10.1111/j.1600-0625.2008.00806.x. PMID: 19161409.
23. Lee YM, Kang SM, Chung JH. 2012; The role of TRPV1 channel in aged human skin. J Dermatol Sci. 65:81–85. DOI: 10.1016/j.jdermsci.2011.11.003. PMID: 22154816.
Article
24. Jiang SJ, Chu AW, Lu ZF, Pan MH, Che DF, Zhou XJ. 2007; Ultraviolet B-induced alterations of the skin barrier and epidermal calcium gradient. Exp Dermatol. 16:985–992. DOI: 10.1111/j.1600-0625.2007.00619.x. PMID: 18031457.
Article
25. Lee SE, Lee SH. 2018; Skin barrier and calcium. Ann Dermatol. 30:265–275. DOI: 10.5021/ad.2018.30.3.265. PMID: 29853739. PMCID: PMC5929942.
Article
26. Tajima R, Oozeki H, Muraoka S, Tanaka S, Motegi Y, Nihei H, Yamada Y, Masuoka N, Nihei K. 2011; Synthesis and evaluation of bibenzyl glycosides as potent tyrosinase inhibitors. Eur J Med Chem. 46:1374–1381. DOI: 10.1016/j.ejmech.2011.01.065. PMID: 21334791.
Article
27. Bellono NW, Oancea EV. 2014; Ion transport in pigmentation. Arch Biochem Biophys. 563:35–41. DOI: 10.1016/j.abb.2014.06.020. PMID: 25034214. PMCID: PMC4497562.
Article
28. Caterina MJ, Pang Z. 2016; TRP channels in skin biology and pathophysiology. Pharmaceuticals (Basel). 9:77. DOI: 10.3390/ph9040077. PMID: 27983625. PMCID: PMC5198052.
Article
29. Elsholz F, Harteneck C, Muller W, Friedland K. 2014; Calcium--a central regulator of keratinocyte differentiation in health and disease. Eur J Dermatol. 24:650–661. DOI: 10.1684/ejd.2014.2452. PMID: 25514792.
30. Abdel-Malek ZA, Kadekaro AL, Swope VB. 2010; Stepping up melanocytes to the challenge of UV exposure. Pigment Cell Melanoma Res. 23:171–186. DOI: 10.1111/j.1755-148X.2010.00679.x. PMID: 20128873.
Article
31. Lee AY. 2015; Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 28:648–660. DOI: 10.1111/pcmr.12404. PMID: 26230865.
Article
32. Schallreuter KU, Kothari S, Chavan B, Spencer JD. 2008; Regulation of melanogenesis--controversies and new concepts. Exp Dermatol. 17:395–404. DOI: 10.1111/j.1600-0625.2007.00675.x. PMID: 18177348.
33. Wicks NL, Chan JW, Najera JA, Ciriello JM, Oancea E. 2011; UVA phototransduction drives early melanin synthesis in human melanocytes. Curr Biol. 21:1906–1911. DOI: 10.1016/j.cub.2011.09.047. PMID: 22055294. PMCID: PMC3586554.
Article
34. Bellono NW, Kammel LG, Zimmerman AL, Oancea E. 2013; UV light phototransduction activates transient receptor potential A1 ion channels in human melanocytes. Proc Natl Acad Sci U S A. 110:2383–2388. DOI: 10.1073/pnas.1215555110. PMID: 23345429. PMCID: PMC3568351.
Article
Full Text Links
  • KJPP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr